Your browser doesn't support javascript.
loading
Why ketamine.
Coles, Lisa; Rosenthal, Eric S; Bleck, Thomas P; Elm, Jordan; Zehtabchi, Shahriar; Chamberlain, James; Cloyd, James; Shinnar, Shlomo; Silbergleit, Robert; Kapur, Jaideep.
Afiliación
  • Coles L; Center for Orphan Drug Research, Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, MN, United States.
  • Rosenthal ES; Department of Neurology, Massachusetts General Hospital, Boston, MA, United States.
  • Bleck TP; Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL, United States.
  • Elm J; Department of Public Health Sciences, Medical University of South Carolina, Charleston, SC, United States.
  • Zehtabchi S; Department of Emergency Medicine, Downstate Health Sciences University, Brooklyn, NY, United States.
  • Chamberlain J; Division of Emergency Medicine, Children's National Hospital Washington, DC, United States.
  • Cloyd J; Center for Orphan Drug Research, Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, MN, United States.
  • Shinnar S; Departments of Neurology, Pediatrics, Epidemiology and Public Health, Albert Einstein College of Medicine, Bronx, NY, United States.
  • Silbergleit R; Department of Emergency Medicine, University of Michigan, School of Medicine, Ann Arbor, MI, United States.
  • Kapur J; Department of Neurology and Neuroscience, University of Virginia, School of Medicine, Charlottesville, VA, United States. Electronic address: jk8t@virginia.edu.
Epilepsy Behav ; 141: 109066, 2023 04.
Article en En | MEDLINE | ID: mdl-36609129
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Estado Epiléptico / Fármacos Neuroprotectores / Ketamina Límite: Humans Idioma: En Revista: Epilepsy Behav Asunto de la revista: CIENCIAS DO COMPORTAMENTO / NEUROLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Estado Epiléptico / Fármacos Neuroprotectores / Ketamina Límite: Humans Idioma: En Revista: Epilepsy Behav Asunto de la revista: CIENCIAS DO COMPORTAMENTO / NEUROLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos